AM
Andros Medicines Inc.
SEC filingPharmaceuticals · Boston, MA
Amount raised$3Msold at filing
Total offering$5M$2M still open
Investors in the raise2count reported to the SEC
FiledJul 1, 2026first sale Jun 18, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Antoine BaroukyDirector
John MaraganoreExecutive Officer, Director
Khalil BarrageDirector
Executive officers, directors and promoters as listed on the Form D.